Regeneron's CD20xCD3 bispecific antibody for ... and 163,000 cases of DLBCL. "Building upon this approval, we are excited about our OLYMPIA program, which includes multiple phase 3 trials ...

The 3.2 million-square-foot distribution center for Amazon would rise nearly five stories at the site, if the plans are approved.

Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.

Louisiana has lost 2,000 square miles of coastal wetlands since the 1930s. A Baton Rouge Magnet High student is studying the ...

BIOPHARMACEUTICAL firm Regeneron is to formally seek planning ... She also welcomed the building jobs, saying 250 is “a massive number of people”. “The construction industry has a long ...

BASIS Independent Schools is scheduled to open its third private institution in the Bay Area for grades sixth through 12th by ...

Regeneron Pharmaceuticals announced positive three-year results from an extension study of EYLEA HD (aflibercept) Injection 8 mg for treating wet age-related macular degeneration (wAMD). The ...

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of EYLEA HD (aflibercept) Injection 8 mg for treating ...

TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: TD Cowen 45th Annual Health Care Conference at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...